Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2021
Materias:	\|contrast-enhanced ultrasound\|hepatocellular carcinoma\|transarterial radioembolization\|transarterial chemoembolization\|treatment response Medical technology R855-855.5 Medicine R
Acceso en línea:	https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1eb063ed83bc4dde8db81afc1a651394
record_format	dspace
spelling	oai:doaj.org-article:1eb063ed83bc4dde8db81afc1a6513942021-11-05T08:34:43ZContrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization2576-251610.37015/AUDT.2021.210018https://doaj.org/article/1eb063ed83bc4dde8db81afc1a6513942021-09-01T00:00:00Zhttp://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/1630472714054-727648893.pdfhttps://doaj.org/toc/2576-2516Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhDEditorial Office of Advanced Ultrasound in Diagnosis and Therapyarticle\|contrast-enhanced ultrasound\|hepatocellular carcinoma\|transarterial radioembolization\|transarterial chemoembolization\|treatment responseMedical technologyR855-855.5MedicineRENAdvanced Ultrasound in Diagnosis and Therapy, Vol 5, Iss 3, Pp 254-257 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	\|contrast-enhanced ultrasound\|hepatocellular carcinoma\|transarterial radioembolization\|transarterial chemoembolization\|treatment response Medical technology R855-855.5 Medicine R
spellingShingle	\|contrast-enhanced ultrasound\|hepatocellular carcinoma\|transarterial radioembolization\|transarterial chemoembolization\|treatment response Medical technology R855-855.5 Medicine R Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
description	Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.
format	article
author	Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
author_facet	Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
author_sort	Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
title	Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
title_short	Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
title_full	Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
title_fullStr	Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
title_full_unstemmed	Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
title_sort	contrast-enhanced ultrasound assessment of treatment response in a patient with multifocal hepatocellular carcinoma treated with transarterial chemo and radioembolization
publisher	Editorial Office of Advanced Ultrasound in Diagnosis and Therapy
publishDate	2021
url	https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394
work_keys_str_mv	AT esikasavsanimohamedtantawimdcorinneewessnermbardmsrvtphilipleemdandrejlyshchikmdphdkevinantonmdphdcolettemshawmdjibinliumdjohnreisenbreyphd contrastenhancedultrasoundassessmentoftreatmentresponseinapatientwithmultifocalhepatocellularcarcinomatreatedwithtransarterialchemoandradioembolization
_version_	1718444453875679232

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Ejemplares similares